A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation

Condition:   Recurrent Hepatocellular Carcinoma Intervention:   Biological: LioCyx Sponsors:   Lion TCR Pte. Ltd.;   Agency for Science, Technology and Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials